Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 10 studies | 36% ± 23% | |
| amacrine cell | 6 studies | 36% ± 12% | |
| GABAergic neuron | 6 studies | 52% ± 23% | |
| interneuron | 5 studies | 43% ± 25% | |
| retinal ganglion cell | 4 studies | 45% ± 19% | |
| neuron | 3 studies | 20% ± 4% | |
| oligodendrocyte precursor cell | 3 studies | 23% ± 5% | |
| granule cell | 3 studies | 32% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 34% ± 21% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 96% | 7449.33 | 2530 / 2642 | 92% | 6.51 | 647 / 705 |
| adrenal gland | 6% | 37.66 | 16 / 258 | 54% | 2.05 | 125 / 230 |
| muscle | 13% | 46.82 | 103 / 803 | 0% | 0 | 0 / 0 |
| breast | 3% | 6.70 | 12 / 459 | 7% | 0.42 | 82 / 1118 |
| uterus | 3% | 20.50 | 5 / 170 | 4% | 0.09 | 19 / 459 |
| pancreas | 1% | 1.44 | 2 / 328 | 6% | 0.30 | 10 / 178 |
| intestine | 5% | 11.38 | 45 / 966 | 1% | 0.02 | 6 / 527 |
| prostate | 3% | 7.06 | 8 / 245 | 1% | 0.02 | 4 / 502 |
| ovary | 1% | 5.30 | 2 / 180 | 3% | 0.07 | 11 / 430 |
| skin | 0% | 0.83 | 5 / 1809 | 3% | 0.06 | 14 / 472 |
| eye | 0% | 0 | 0 / 0 | 3% | 0.11 | 2 / 80 |
| liver | 1% | 4.11 | 2 / 226 | 1% | 0.03 | 6 / 406 |
| tonsil | 0% | 0 | 0 / 0 | 2% | 0.05 | 1 / 45 |
| stomach | 0% | 0 | 0 / 359 | 2% | 0.07 | 6 / 286 |
| lung | 0% | 0 | 0 / 578 | 2% | 0.05 | 24 / 1155 |
| bladder | 0% | 0 | 0 / 21 | 2% | 0.06 | 10 / 504 |
| thymus | 0% | 0.27 | 1 / 653 | 1% | 0.05 | 8 / 605 |
| kidney | 0% | 0 | 0 / 89 | 1% | 0.04 | 13 / 901 |
| esophagus | 0% | 0.40 | 2 / 1445 | 1% | 0.01 | 1 / 183 |
| heart | 0% | 0.35 | 1 / 861 | 0% | 0 | 0 / 0 |
| blood vessel | 0% | 0.26 | 1 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| adipose | 0% | 0 | 0 / 1204 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_1901381 | Biological process | positive regulation of potassium ion transmembrane transport |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0006813 | Biological process | potassium ion transport |
| GO_0010996 | Biological process | response to auditory stimulus |
| GO_0014075 | Biological process | response to amine |
| GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
| GO_0035864 | Biological process | response to potassium ion |
| GO_0071805 | Biological process | potassium ion transmembrane transport |
| GO_0099505 | Biological process | regulation of presynaptic membrane potential |
| GO_0021554 | Biological process | optic nerve development |
| GO_0051262 | Biological process | protein tetramerization |
| GO_0021759 | Biological process | globus pallidus development |
| GO_0071774 | Biological process | response to fibroblast growth factor |
| GO_0009642 | Biological process | response to light intensity |
| GO_0022038 | Biological process | corpus callosum development |
| GO_0021549 | Biological process | cerebellum development |
| GO_0009636 | Biological process | response to toxic substance |
| GO_0001508 | Biological process | action potential |
| GO_1990089 | Biological process | response to nerve growth factor |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0043679 | Cellular component | axon terminus |
| GO_0032809 | Cellular component | neuronal cell body membrane |
| GO_0042734 | Cellular component | presynaptic membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0030673 | Cellular component | axolemma |
| GO_0044305 | Cellular component | calyx of Held |
| GO_0045211 | Cellular component | postsynaptic membrane |
| GO_0032590 | Cellular component | dendrite membrane |
| GO_0008076 | Cellular component | voltage-gated potassium channel complex |
| GO_0005249 | Molecular function | voltage-gated potassium channel activity |
| GO_0005251 | Molecular function | delayed rectifier potassium channel activity |
| GO_0099508 | Molecular function | voltage-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential |
| GO_0044325 | Molecular function | transmembrane transporter binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0019894 | Molecular function | kinesin binding |
| Gene name | KCNC1 |
| Protein name | Potassium voltage-gated channel subfamily C member 1 Potassium voltage-gated channel subfamily C member 1 (NGK2) (Voltage-gated potassium channel subunit Kv3.1) (Voltage-gated potassium channel subunit Kv4) |
| Synonyms | |
| Description | FUNCTION: Voltage-gated potassium channel that plays an important role in the rapid repolarization of fast-firing brain neurons. The channel opens in response to the voltage difference across the membrane, forming a potassium-selective channel through which potassium ions pass in accordance with their electrochemical gradient . Can form functional homotetrameric channels and heterotetrameric channels that contain variable proportions of KCNC2, and possibly other family members as well. Contributes to fire sustained trains of very brief action potentials at high frequency in pallidal neurons. . |
| Accessions | ENST00000639325.2 ENST00000638366.1 P48547 ENST00000640318.2 ENST00000379472.4 [P48547-1] ENST00000640909 ENST00000265969.8 [P48547-2] A0A1W2PP60 ENST00000640461.1 ENST00000675775.1 A0A1W2PPX0 A0A1W2PPT0 A0A1W2PNZ3 ENST00000639495.1 A0A1W2PNN0 A0A6Q8PHL6 A0A1W2PPN9 ENST00000640909.2 [P48547-2] ENST00000638825.1 |
